Social Capital Suvretta Holdings Corp. IV
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DNAD research report →
Price Chart
About the company
Social Capital Suvretta Holdings Corp. IV currently lacks any substantial commercial operations. Its primary objective is to execute a strategic corporate integration, which could take the form of a merger, stock exchange, asset acquisition, equity purchase, or a similar restructuring, specifically targeting companies within the biotechnology sector.
- CEO
- Chamath Palihapitiya
- IPO
- 2021
- HQ
- Henderson, NV, US
Get TickerSpark's AI analysis on DNAD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $329.75M
- P/E
- 41.36
- PEG
- 0.01
- P/S
- 0.00
- P/B
- 1.08
- EV/EBITDA
- -379.45
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 2.59%
- ROIC
- -0.34%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-868,672
- Net Income
- $6.34M+0.0%
- EPS
- $0.25+0.0%
- OCF Growth
- +71.9%
- FCF Growth
- +71.9%
- 52W High
- $10.92
- 52W Low
- $9.70
- 50D MA
- $10.30
- 200D MA
- $10.10
- Beta
- 0.00
- RSI (14)
- 65
- Avg Volume
- 114.55K
No earnings-call transcripts are available for DNAD yet.
- Free Float
- 60.4%
- Shares Outstanding
- 31.89M
- Float Shares
- 19.27M
of shares held by institutions
64 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Davidson Kempner Partners | 200.00K | ▲ 200.00K |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 7, 22 | NEWELL WILLIAM J | other | 0 |
| Jun 29, 22 | Amin Biren | other | 0 |
| Sep 24, 21 | Solomon Steven Marc | other | 0 |
| Aug 16, 21 | SCS Sponsor IV LLC | sell | 75,000 |
| Jul 2, 21 | SCS Sponsor IV LLC | other | 640,000 |
| Jun 29, 21 | SCS Sponsor IV LLC | other | 6,295,000 |
| Jun 29, 21 | Munshi Amit | other | 30,000 |
| Jun 29, 21 | Ryans James | other | 0 |
| Jun 29, 21 | Katz Shoney | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DNAD coverage
Recent articles, reports, and earnings notes.
No research on DNAD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DNAD report →